Back to Search
Start Over
Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement.
- Source :
-
European heart journal [Eur Heart J] 2008 Feb; Vol. 29 (4), pp. 557-63. Date of Electronic Publication: 2008 Jan 17. - Publication Year :
- 2008
-
Abstract
- Mortality rates due to coronary artery disease (CAD) have declined in recent years as result of improved prevention, diagnosis, and management. Nonetheless, CAD remains the leading cause of death worldwide with most casualties expected to occur in developing nations. Myocardial perfusion scintigraphy (MPS) provides a highly cost-effective tool for the early detection of obstructive CAD in symptomatic individuals and contributes substantially to stratification of patients according to their risk of cardiac death or nonfatal myocardial infarction. MPS also provides valuable information that assists clinical decision-making with regard to medical treatment and intervention. A large body of evidence supports the current applications of MPS, which has become integral to several guidelines for clinical practice.
- Subjects :
- Acute Coronary Syndrome diagnostic imaging
Acute Coronary Syndrome mortality
Angina Pectoris diagnostic imaging
Angina Pectoris mortality
Coronary Artery Disease mortality
Cost-Benefit Analysis
Humans
Myocardial Infarction diagnostic imaging
Myocardial Infarction economics
Myocardial Infarction mortality
Practice Guidelines as Topic standards
Prognosis
Tomography, Emission-Computed economics
Tomography, Emission-Computed methods
Coronary Artery Disease diagnostic imaging
Tomography, Emission-Computed standards
Subjects
Details
- Language :
- English
- ISSN :
- 0195-668X
- Volume :
- 29
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- European heart journal
- Publication Type :
- Academic Journal
- Accession number :
- 18202253
- Full Text :
- https://doi.org/10.1093/eurheartj/ehm607